\n\n5 mg \/ ml Infusion solution
nelarabine<\/p>\n\n\n\n
Atriance contains nelarabine belonging to a group of products known as a ntineoplastiska agents,<\/em> which are used in chemotherapy to kill certain types of cancer cells.<\/p>\n\n\n\n Atriance is used to treat patients with:<\/strong><\/p>\n\n\n\n If you have any further questions on the use of this product, ask your doctor. Severe side effects on the nervous system have been reported during treatment with Atriance. Symptoms can be mental (eg fatigue) or physical (leg cramps, numbness or tingling, weakness and paralysis). Your doctor will regularly examine you during treatment for these symptoms (see also section 4, \u201cPossible side effects\u201d).<\/strong> Before taking this medicine, your doctor must tell you:<\/p>\n\n\n\n Blood tests during treatment<\/strong><\/p>\n\n\n\n Your doctor will take regular blood tests during treatment to detect any blood problems that have been linked to the use of Atriance. Older<\/strong><\/p>\n\n\n\n If you are an elderly person, you may be more sensitive to side effects on the nervous system (see “Warnings and Precautions”). Your doctor will regularly examine you during treatment for these symptoms. Tell your doctor if any of these apply to you.<\/strong><\/p>\n\n\n\n Tell your doctor or pharmacist if you are taking, have recently taken or might take any other medicines. This also applies to all natural remedies or medicines that you bought without a prescription. Remember to tell your doctor if you start taking any other medicines while you are receiving Atriance.<\/p>\n\n\n\n Atriance is not recommended for pregnant women. It can harm a baby born before, during or shortly after treatment. You should discuss with your doctor which contraceptive method is right for you. Do not try to get pregnant, or if you are a man, give birth to a child until your doctor says it is safe to do so. Male patients who wish to have a child should ask their doctor for advice on family planning or treatment. If pregnancy occurs during treatment with Atriance, you must tell your doctor immediately. It is not known if Atriance passes into breast milk. Breast-feeding must be stopped while you are being treated with Atriance. Ask your doctor or pharmacist for advice before taking any medicine.<\/p>\n\n\n\n Atriance can make people feel drowsy or sleepy both during and a few days after treatment. If you feel tired or weak, do not drive or use any tools or machines.<\/p>\n\n\n\n This medicine contains 88.51 mg (3.85 mmol) of sodium (the main ingredient in common salt \/ table salt) per vial (50 ml). This corresponds to 4.4% of the highest recommended daily intake of sodium for adults. The Atriance- dose you receive is based on:<\/p>\n\n\n\n Adults and adolescents (16 years and older)<\/strong> <\/p>\n\n\n\n The usual dose a<\/strong> is 1500 mg \/ m 2<\/sup> of body surface per day. A doctor or nurse<\/strong> will give you a dose of Atriance as an infusion (drip). You usually get the drop in your arm for about 2 hours. You will receive an infusion (drip) once daily, days 1, 3 and 5 of the treatment<\/strong> . This treatment schedule is normally repeated every three weeks. The treatment may change depending on the results of the blood tests taken regularly. The doctor decides how many treatment periods are needed. Children and adolescents (21 years and younger)<\/strong> <\/p>\n\n\n\n The recommended dose is 650 mg \/ m 2<\/sup> body surface area per day. A doctor or nurse<\/strong> will give you \/ your child (if he \/ she is being treated) the right dose of Atriance as an infusion<\/em> (drip). You usually get the drop in your arm for about 1 hour. You \/ your child (if he \/ she is treated) will receive an infusion (drip) once daily for 5 days<\/strong> . This treatment schedule is normally repeated every three weeks. The treatment may change depending on the results of the blood tests taken regularly. The doctor decides how many treatment periods are needed.<\/p>\n\n\n\n The doctor decides when to stop the treatment. If you have any further questions on the use of this product, ask your doctor or pharmacist.<\/p>\n\n\n\n Like all medicines, this medicine can cause side effects, although not everybody gets them. Most of the side effects reported with Atriance treatment were seen in adults, children and adolescents. Some side effects have been reported more frequently in adult patients. There is no known cause for this. If you have any further questions, ask your doctor. Most serious <\/strong>side effect s<\/strong><\/p>\n\n\n\n These side effects may affect more than 1 in 10 people treated with Adriance.<\/p>\n\n\n\n Tell<\/strong> your doctor immediately if<\/strong> you get any of these side effects . A blood sample is taken to check for a possible reduction in the white blood cells . Other very common side effects are<\/strong><\/p>\n\n\n\n These side effects may affect more than 1 in 10 people<\/strong> treated with Atriance.<\/p>\n\n\n\n Tell your doctor<\/strong> if any of these side effects gets serious. Common side effects are<\/strong><\/p>\n\n\n\n These can occur in up to 1 in 10 people<\/strong> treated with Atriance: Tell your doctor<\/strong> if any of these side effects gets serious. Rare side effects are<\/strong><\/p>\n\n\n\n These can occur in up to 1 in 1,000 people<\/strong> treated with Atriance:<\/p>\n\n\n\n Tell your doctor<\/strong> if any of these become troublesome. Reporting of side effects<\/em><\/p>\n\n\n\n If you get any side effects, talk to your doctor, pharmacist, or nurse. This includes any possible side effects not listed in this leaflet. You can also report side effects directly to the Medical Products Agency, www.lakemedelsverket.se. By reporting side effects, you can help increase drug safety information. <\/p>\n\n\n\n Keep this medicine out of the sight and reach of children. Do not use this medicine after the expiry date which is stated on the carton and vial. This medicine does not require any special storage instructions. Atriance is stable for up to 8 hours at up to 30 \u00b0 C after opening the vial Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment.<\/p>\n\n\n\n Atriance infusion solution is a clear, colorless solution. It is supplied in clear glass vials with a rubber stopper with an aluminum seal. Each vial contains 50 ml. Atriance is available in packs of 1 vial or 6 vials.<\/p>\n\n\n\n Novartis Europharm Limited<\/p>\n\n\n\n Vista Building<\/p>\n\n\n\n Elm Park, Merrion Road<\/p>\n\n\n\n Dublin 4<\/p>\n\n\n\n Ireland Manufacturer<\/strong><\/p>\n\n\n\n EBEWE Pharma Ges.mbH Nfg.KG<\/p>\n\n\n\n Mondseestrasse 11<\/p>\n\n\n\n 4866 Unterach am Attersee<\/p>\n\n\n\n Austria Novartis Pharmac\u00e9utica SA<\/p>\n\n\n\n Ronda de Santa Maria 158<\/p>\n\n\n\n 08210 Barber\u00e0 del Vall\u00e8s, Barcelona<\/p>\n\n\n\n Spain Novartis Pharma GmbH<\/p>\n\n\n\n Roonstra\u00dfe 25<\/p>\n\n\n\n D-90429 Nuremberg<\/p>\n\n\n\n Germany Contact the representative of the marketing authorization holder to find out more about this medicine:<\/p>\n\n\n\n Atriance contains nelarabine belonging to a group of products known as a ntineoplastiska agents, which are used in chemotherapy to kill certain types of cancer cells.<\/p>\n","protected":false},"author":2,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"cybocfi_hide_featured_image":"","footnotes":""},"categories":[2201,2200],"tags":[9719,9714,9717,9722,9718,9721,9720,9715,9716],"class_list":["post-5719","post","type-post","status-publish","format-standard","hentry","category-a","category-medicines","tag-atriance","tag-nelarabine","tag-nelarabine-side-effects","tag-side-effects-of-atriance","tag-side-effects-of-nelarabine","tag-what-atriance-is-used-for","tag-what-is-atriance","tag-what-is-nelarabine","tag-what-nelarabine-is-used-for"],"_links":{"self":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/5719","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/comments?post=5719"}],"version-history":[{"count":5,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/5719\/revisions"}],"predecessor-version":[{"id":12333,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/posts\/5719\/revisions\/12333"}],"wp:attachment":[{"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/media?parent=5719"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/categories?post=5719"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/zeepedia.com\/medical\/wp-json\/wp\/v2\/tags?post=5719"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}
<\/p>\n\n\n\n2. What you need to know before you get Atriance<\/h2>\n\n\n\n
You (or your child, if he \/ she is treated) should not be treated with Atriance<\/h2>\n\n\n\n
Warnings and cautions<\/h2>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\nOther drugs and Atriance<\/h2>\n\n\n\n
<\/p>\n\n\n\nPregnancy, breastfeeding and fertility<\/h2>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\nDriving and using machines<\/h2>\n\n\n\n
Atriance contains sodium<\/h2>\n\n\n\n
<\/p>\n\n\n\n3. How Atriance is given<\/h2>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\nDiscontinue treatment with Atriance<\/h2>\n\n\n\n
<\/p>\n\n\n\n4. Possible side effects<\/h2>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n5. How to store Atriance<\/h2>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n6. Contents of the packaging and other information<\/h2>\n\n\n\n
Content declaration<\/h2>\n\n\n\n
What the medicine looks like and the contents of the pack<\/h2>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\nMarketing Authorisation Holder<\/h2>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\n
<\/p>\n\n\n\nBelgium \/ Belgique \/ Belgien<\/strong>Novartis Pharma NVTel: +32 2 246 16 11<\/td> Lithuania<\/strong>SIA Novartis Baltics Lithuanian branchesTel: +370 5 269 16 50<\/td><\/tr> Bulgaria<\/strong>Novartis Bulgaria EOODTel: +359 2 489 98 28<\/td> Luxembourg \/ Luxemburg<\/strong>Novartis Pharma NVTel: +32 2 246 16 11<\/td><\/tr> Czech Republic<\/strong>Novartis sroTel: +420 225 775 111<\/td> Hungary<\/strong>Novartis Hungary Kft.Tel .: +36 1 457 65 00<\/td><\/tr> Denmark<\/strong>Sandoz A \/ STel: +45 63 95 10 00<\/td> Malta<\/strong>Novartis Pharma Services Inc.Tel: +356 2122 2872<\/td><\/tr> Germany<\/strong>Novartis Pharma GmbHTel: +49 911 273 0<\/td> The Netherlands<\/strong>Novartis Pharma BVTel: +31 88 04 52 555<\/td><\/tr> Eesti<\/strong>SIA Novartis Baltics Eesti subsidiaryTel: +372 66 30 810<\/td> Norway<\/strong>Sandoz A \/ STel: +45 63 95 10 00<\/td><\/tr> Greece<\/strong>Novartis (Hellas) AEBE:\u0397\u03bb: +30 210 281 17 12<\/td> Austria<\/strong>Novartis Pharma GmbHTel: +43 1 86 6570<\/td><\/tr> Spain<\/strong>BEXAL PHARMACEUTICALS, SATel: +34 900 456 856<\/td> Poland<\/strong>Novartis Poland Sp. z ooTel .: +48 22 375 4888<\/td><\/tr> France<\/strong>SandozTel: +33 800 45 57 99<\/td> Portugal<\/strong>Novartis Farma – Pharmaceutical Products, SATel: +351 21 000 8600<\/td><\/tr> Croatia<\/strong>Novartis Hrvatska dooTel. +385 1 6274 220<\/td> Romania<\/strong>Sandoz SRLTel: +40 021 4075160<\/td><\/tr> Ireland<\/strong>Novartis Ireland LimitedTel: +353 1 260 12 55<\/td> Slovenia<\/strong>Novartis Pharma Services Inc.Tel: +386 1 300 75 50<\/td><\/tr> Iceland<\/strong>Vistor hf.Phone: +354 535 7000<\/td> Slovak Republic<\/strong>Novartis Slovakia sroTel: +421 2 5542 5439<\/td><\/tr> Italy<\/strong>Novartis Farma SpATel: +39 02 96 54 1<\/td> Finland \/ Finland<\/strong>Novartis Finland OyPuh \/ Tel: +358 (0) 10 6133 200<\/td><\/tr> \u039a\u03cd\u03c0\u03c1\u03bf\u03c2<\/strong>Novartis Pharma Services Inc.:\u0397\u03bb: +357 22 690 690<\/td> <\/td><\/tr> Latvia<\/strong>SIA Novartis BalticsTel: +371 67 887 070<\/td> United Kingdom<\/strong>Novartis Pharmaceuticals UK Ltd.Tel: +44 1276 698370<\/td><\/tr><\/tbody><\/table><\/figure>\n","protected":false},"excerpt":{"rendered":"